Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Efficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients.

Yoshida N, Hosokawa T, Ishikawa T, Yagi N, Kokura S, Naito Y, Nakanishi M, Kokuba Y, Otsuji E, Kuroboshi H, Taniwaki M, Taguchi T, Hosoi H, Nakamura T, Miki T.

J Oncol. 2013;2013:139740. doi: 10.1155/2013/139740. Epub 2013 Nov 7.

PMID:
24307899
[PubMed]
Free PMC Article
2.

The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen.

Nishioka M, Shimada M, Kurita N, Iwata T, Morimoto S, Yoshikawa K, Higashijima J, Miyatani T, Kono T.

Int J Clin Oncol. 2011 Aug;16(4):322-7. doi: 10.1007/s10147-010-0183-1. Epub 2011 Jan 22.

PMID:
21258836
[PubMed - indexed for MEDLINE]
3.

Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer.

Kono T, Mamiya N, Chisato N, Ebisawa Y, Yamazaki H, Watari J, Yamamoto Y, Suzuki S, Asama T, Kamiya K.

Evid Based Complement Alternat Med. 2011;2011:418481. doi: 10.1093/ecam/nep200. Epub 2011 Jan 11.

PMID:
19952054
[PubMed]
Free PMC Article
4.

Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study.

Kaku H, Kumagai S, Onoue H, Takada A, Shoji T, Miura F, Yoshizaki A, Sato S, Kigawa J, Arai T, Tsunoda S, Tominaga E, Aoki D, Sugiyama T.

Exp Ther Med. 2012 Jan;3(1):60-65. Epub 2011 Oct 24.

PMID:
22969845
[PubMed]
Free PMC Article
5.

Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.

Ushio S, Egashira N, Sada H, Kawashiri T, Shirahama M, Masuguchi K, Oishi R.

Eur J Cancer. 2012 Jun;48(9):1407-13. doi: 10.1016/j.ejca.2011.08.009. Epub 2011 Sep 8.

PMID:
21907570
[PubMed - indexed for MEDLINE]
6.

Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat.

Mizuno K, Kono T, Suzuki Y, Miyagi C, Omiya Y, Miyano K, Kase Y, Uezono Y.

J Pharmacol Sci. 2014;125(1):91-8. Epub 2014 Apr 29.

PMID:
24784702
[PubMed - in process]
Free Article
7.

Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients.

Wang WS, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Chiou TJ, Liu JH, Yen CC, Chen PM.

Oncologist. 2007 Mar;12(3):312-9.

PMID:
17405895
[PubMed - indexed for MEDLINE]
Free Article
8.

[Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study].

Eckel F, Schmelz R, Adelsberger H, Erdmann J, Quasthoff S, Lersch C.

Dtsch Med Wochenschr. 2002 Jan 18;127(3):78-82. German.

PMID:
11797144
[PubMed - indexed for MEDLINE]
9.

Ca/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis.

Wen F, Zhou Y, Wang W, Hu QC, Liu YT, Zhang PF, Du ZD, Dai J, Li Q.

Ann Oncol. 2013 Jan;24(1):171-8. doi: 10.1093/annonc/mds211. Epub 2012 Aug 16.

PMID:
22898039
[PubMed - indexed for MEDLINE]
Free Article
10.

Preventive effect of traditional Japanese medicine on neurotoxicity of FOLFOX for metastatic colorectal cancer: a multicenter retrospective study.

Hosokawa A, Ogawa K, Ando T, Suzuki N, Ueda A, Kajiura S, Kobayashi Y, Tsukioka Y, Horikawa N, Yabushita K, Fukuoka J, Sugiyama T.

Anticancer Res. 2012 Jul;32(7):2545-50.

PMID:
22753712
[PubMed - indexed for MEDLINE]
11.

Herbal Medicine Goshajinkigan Prevents Paclitaxel-Induced Mechanical Allodynia without Impairing Antitumor Activity of Paclitaxel.

Bahar MA, Andoh T, Ogura K, Hayakawa Y, Saiki I, Kuraishi Y.

Evid Based Complement Alternat Med. 2013;2013:849754. doi: 10.1155/2013/849754. Epub 2013 Oct 2.

PMID:
24198846
[PubMed]
Free PMC Article
12.

Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?

Madbouly KM, Hussein AM, Zeid A.

Dis Colon Rectum. 2013 May;56(5):577-85. doi: 10.1097/DCR.0b013e318286f8fc.

PMID:
23575396
[PubMed - indexed for MEDLINE]
13.

Clinical study on the prevention of oxaliplatin-induced neurotoxicity with guilongtongluofang: results of a randomized, double-blind, placebo-controlled trial.

Liu Y, Zhu G, Han L, Liu J, Ma T, Yu H.

Evid Based Complement Alternat Med. 2013;2013:541217. doi: 10.1155/2013/541217. Epub 2013 Nov 13.

PMID:
24324514
[PubMed]
Free PMC Article
14.

Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.

Ramanathan RK, Rothenberg ML, de Gramont A, Tournigand C, Goldberg RM, Gupta S, André T.

Ann Oncol. 2010 Apr;21(4):754-8. doi: 10.1093/annonc/mdp509. Epub 2009 Nov 3.

PMID:
19887466
[PubMed - indexed for MEDLINE]
Free Article
15.

Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients.

Sugimoto S, Katano K, Kanazawa A, Yoshimura H, Kidani A, Takeda H, Makino M, Ozaki N, Tanaka T, Ikeguchi M.

J Exp Clin Cancer Res. 2009 Aug 7;28:109. doi: 10.1186/1756-9966-28-109.

PMID:
19664225
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Impact of oxaliplatin-induced neuropathy: a patient perspective.

Bennett BK, Park SB, Lin CS, Friedlander ML, Kiernan MC, Goldstein D.

Support Care Cancer. 2012 Nov;20(11):2959-67. doi: 10.1007/s00520-012-1428-5. Epub 2012 Mar 17.

PMID:
22426503
[PubMed - indexed for MEDLINE]
17.

A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.

Vatandoust S, Joshi R, Pittman KB, Esterman A, Broadbridge V, Adams J, Singhal N, Yeend S, Price TJ.

Support Care Cancer. 2014 Feb;22(2):513-8.

PMID:
24122404
[PubMed - in process]
18.

Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study.

Custodio A, Moreno-Rubio J, Aparicio J, Gallego-Plazas J, Yaya R, Maurel J, Higuera O, Burgos E, Ramos D, Calatrava A, Andrada E, López R, Moreno V, Madero R, Cejas P, Feliu J.

Ann Oncol. 2014 Feb;25(2):398-403. doi: 10.1093/annonc/mdt546. Epub 2013 Dec 18.

PMID:
24351404
[PubMed - in process]
19.

The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: a retrospective study.

Chen XF, Wang R, Yin YM, Røe OD, Li J, Zhu LJ, Guo RH, Wu T, Shu YQ.

Biomed Pharmacother. 2012 Jun;66(4):279-84. doi: 10.1016/j.biopha.2012.01.002. Epub 2012 Feb 17.

PMID:
22397758
[PubMed - indexed for MEDLINE]
20.

A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration.

Beijers AJ, Mols F, Vreugdenhil G.

Support Care Cancer. 2014 Jul;22(7):1999-2007. doi: 10.1007/s00520-014-2242-z. Epub 2014 Apr 13.

PMID:
24728618
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk